Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Jouanneau, E; Alberti, L; Nejjari, M; Treilleux, I; Vilgrain, I; Duc, A; Combaret, V; Favrot, M; Leboulch, P; Bachelot, T
   Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model
   JOURNAL OF NEURO-ONCOLOGY
   
   E. Jouanneau et al., "Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model", J NEURO-ONC, 51(1), 2001, pp. 11-18
2. Vandesompele, J; Speleman, F; Van Roy, N; Laureys, C; Brinkschmidt, C; Christiansen, H; Lampert, F; Lastowska, M; Bown, N; Pearson, A; Nicholson, JC; Ross, F; Combaret, V; Delattre, O; Feuerstein, BC; Plantaz, D
   Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?
   MEDICAL AND PEDIATRIC ONCOLOGY
   
   J. Vandesompele et al., "Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?", MED PED ONC, 36(1), 2001, pp. 5-10
3. Plantaz, D; Vandesompele, J; Van Roy, N; Lastowska, M; Bown, N; Combaret, V; Favrot, MC; Delattre, O; Michon, J; Benard, J; Hartmann, O; Nicholson, JC; Ross, FM; Brinkschmidt, C; Laureys, G; Caron, H; Matthay, KK; Feuerstein, BG; Speleman, F
   Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification
   INTERNATIONAL JOURNAL OF CANCER
   
   D. Plantaz et al., "Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification", INT J CANC, 91(5), 2001, pp. 680-686
4. Thiesse, P; Hany, MA; Combaret, V; Renchere-Vince, D; Bouffet, E; Bergeron, C
   Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma
   EUROPEAN JOURNAL OF CANCER
   
   P. Thiesse et al., "Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma", EUR J CANC, 36(12), 2000, pp. 1544-1551
5. Frappaz, D; Michon, J; Coze, C; Berger, C; Plouvier, E; Lasset, C; Bernard, JL; Stephan, JL; Bouffet, E; Buclon, M; Combaret, V; Fourquet, A; Philip, T; Zucker, JM
   LMCE3 treatment strategy: Results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis
   JOURNAL OF CLINICAL ONCOLOGY
   
   D. Frappaz et al., "LMCE3 treatment strategy: Results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis", J CL ONCOL, 18(3), 2000, pp. 468-476
6. Tchirkov, A; Kanold, J; Combaret, V; Philip, I; Kwiatkowski, F; Malet, P; Demeocq, F
   Immunological and molecular detection of tumor contamination in leukapheresis products from children with disseminated neuroblastoma: implication forevaluation of tumor cell depletion after CD34 selection
   BONE MARROW TRANSPLANTATION
   
   A. Tchirkov et al., "Immunological and molecular detection of tumor contamination in leukapheresis products from children with disseminated neuroblastoma: implication forevaluation of tumor cell depletion after CD34 selection", BONE MAR TR, 24(2), 1999, pp. 229-230
7. KANOLD J; TCHIRKOV A; HALLE P; BERGER M; RAPATEL C; LUMLEY L; LUTZ P; PLANTAZ D; VANNIER JP; MECHINAUD F; BERGERON C; STEPHAN JL; GIOLLANT M; COMBARET V; DEMEOCQ F
   SUCCESSFUL CD34-BLOOD CELL TRANSPLANTATION IN VERY SMALL CHILDREN WITH NEUROBLASTOMA-PURGE EVALUATION( PERIPHERAL)
   Bone marrow transplantation
   
   J. Kanold et al., "SUCCESSFUL CD34-BLOOD CELL TRANSPLANTATION IN VERY SMALL CHILDREN WITH NEUROBLASTOMA-PURGE EVALUATION( PERIPHERAL)", Bone marrow transplantation, 21, 1998, pp. 30-30
8. COMBARET V; DELATTRE O; BENARD J; FAVROT MC
   PROGNOSTIC VALUE OF BIOLOGICAL MARKERS IN NEUROBLASTOMA - PROPOSAL FOR A METHODOLOGY OF ANALYSIS
   Bulletin du cancer
   
   V. Combaret et al., "PROGNOSTIC VALUE OF BIOLOGICAL MARKERS IN NEUROBLASTOMA - PROPOSAL FOR A METHODOLOGY OF ANALYSIS", Bulletin du cancer, 85(3), 1998, pp. 262-266
9. COLL JL; COMBARET V; METCHLER K; AMSTUTZ H; IACONODICACITO I; SIMON N; FAVROT MC
   IN-VITRO TARGETING AND SPECIFIC TRANSFECTION OF HUMAN NEUROBLASTOMA-CELLS BY CHCE7 ANTIBODY-MEDIATED GENE-TRANSFER
   Gene therapy
   
   J.L. Coll et al., "IN-VITRO TARGETING AND SPECIFIC TRANSFECTION OF HUMAN NEUROBLASTOMA-CELLS BY CHCE7 ANTIBODY-MEDIATED GENE-TRANSFER", Gene therapy, 4(2), 1997, pp. 156-161
10. RUBIE H; DELATTRE O; HARTMANN O; COMBARET V; MICHON J; BENARD J; PEYROULET MC; PLANTAZ D; COZE C; CHASTAGNER P; BARANZELLI MC; FRAPPAZ D; LEMERLE J; SOMMELET D
    LOSS OF CHROMOSOME 1P MAY HAVE A PROGNOSTIC VALUE IN LOCALIZED NEUROBLASTOMA - RESULTS OF THE FRENCH NBL-90 STUDY
    European journal of cancer
    
    H. Rubie et al., "LOSS OF CHROMOSOME 1P MAY HAVE A PROGNOSTIC VALUE IN LOCALIZED NEUROBLASTOMA - RESULTS OF THE FRENCH NBL-90 STUDY", European journal of cancer, 33(12), 1997, pp. 1917-1922
11. COMBARET V; GROSS N; LASSET C; FRAPPAZ D; BERETTABROGNARA C; PHILIP T; BECK D; FAVROT MC
    CLINICAL RELEVANCE OF CD44 CELL-SURFACE EXPRESSION AND MYCN GENE AMPLIFICATION IN NEUROBLASTOMA
    European journal of cancer
    
    V. Combaret et al., "CLINICAL RELEVANCE OF CD44 CELL-SURFACE EXPRESSION AND MYCN GENE AMPLIFICATION IN NEUROBLASTOMA", European journal of cancer, 33(12), 1997, pp. 2101-2105
12. MIRON I; FRAPPAZ D; BRUNATMENTIGNY M; COMBARET V; BUCLON M; BOUFFET E; THIESSE P; RAGG S; BAILLY C; PHILIP T
    INITIAL MANAGEMENT OF ADVANCED BURKITT-LYMPHOMA IN CHILDREN - IS THERE STILL A PLACE FOR SURGERY
    Pediatric hematology and oncology
    
    I. Miron et al., "INITIAL MANAGEMENT OF ADVANCED BURKITT-LYMPHOMA IN CHILDREN - IS THERE STILL A PLACE FOR SURGERY", Pediatric hematology and oncology, 14(6), 1997, pp. 555-561
13. FRAPPAZ D; GIAMMARILE F; THIESSE P; RANCHEREVINCE D; LOUIS D; GUIBAUD L; SOUILLET G; COMBARET V; SCHELL M; BERGERON C
    FALSE-POSITIVE MIBG SCAN
    Medical and pediatric oncology
    
    D. Frappaz et al., "FALSE-POSITIVE MIBG SCAN", Medical and pediatric oncology, 29(6), 1997, pp. 589-592
14. CHAUVIN F; MATHIEU P; FRAPPAZ D; LASSET C; FAVROT MC; GREFFE J; ESTEVE J; THIESSE P; COMBARET V; CHAUVOT P; BOSCHETTI R; DAVID L; BRUNATMENTIGNY M; PHILIP T
    SCREENING FOR NEUROBLASTOMA IN FRANCE - METHODOLOGICAL ASPECTS AND PRELIMINARY-OBSERVATIONS
    Medical and pediatric oncology
    
    F. Chauvin et al., "SCREENING FOR NEUROBLASTOMA IN FRANCE - METHODOLOGICAL ASPECTS AND PRELIMINARY-OBSERVATIONS", Medical and pediatric oncology, 28(2), 1997, pp. 81-91
15. COMBARET V; GROSS N; LASSET C; BALMAS K; BOUVIER R; FRAPPAZ D; BERETTABROGNARA C; PHILIP T; FAVROT MC; COLL JL
    CLINICAL RELEVANCE OF TRKA EXPRESSION ON NEUROBLASTOMA - COMPARISON WITH N-MYC AMPLIFICATION AND CD44 EXPRESSION
    British Journal of Cancer
    
    V. Combaret et al., "CLINICAL RELEVANCE OF TRKA EXPRESSION ON NEUROBLASTOMA - COMPARISON WITH N-MYC AMPLIFICATION AND CD44 EXPRESSION", British Journal of Cancer, 75(8), 1997, pp. 1151-1155
16. FAVROT MC; AMBROS P; SCHILLING F; FRAPPAZ D; COMBARET V; BERTHOLD F; DOMINICI C; ERTTMANN R; ESTEVE J; JENKNER A; KERBL R; MANN J; MATHIEU P; PARKER L; POWELL J; PHILIP T
    COMPARISON OF THE DIAGNOSTIC AND PROGNOSTIC VALUE OF BIOLOGICAL MARKERS IN NEUROBLASTOMA - PROPOSAL FOR A COMMON METHODOLOGY
    Annals of oncology
    
    M.C. Favrot et al., "COMPARISON OF THE DIAGNOSTIC AND PROGNOSTIC VALUE OF BIOLOGICAL MARKERS IN NEUROBLASTOMA - PROPOSAL FOR A COMMON METHODOLOGY", Annals of oncology, 7(6), 1996, pp. 607-611
17. COMBARET V; GROSS N; LASSET C; FRAPPAZ D; PERUISSEAU G; PHILIP T; BECK D; FAVROT MC
    CLINICAL RELEVANCE OF CD44 CELL-SURFACE EXPRESSION AND N-MYC GENE AMPLIFICATION IN A MULTICENTRIC ANALYSIS OF 121 PEDIATRIC NEUROBLASTOMAS
    Journal of clinical oncology
    
    V. Combaret et al., "CLINICAL RELEVANCE OF CD44 CELL-SURFACE EXPRESSION AND N-MYC GENE AMPLIFICATION IN A MULTICENTRIC ANALYSIS OF 121 PEDIATRIC NEUROBLASTOMAS", Journal of clinical oncology, 14(1), 1996, pp. 25-34
18. MATHIEU P; FRAPPAZ D; CHAUVIN F; COMBARET V; VERCHERAT M; BRUNATMENTIGNY M; DAVID L; ESTEVE J; FAVROT M; FOUILLAT V; GREFFE J; LASSET C; RENAUD P; PHILIP T
    A 5-YEAR (1990-1994) NEUROBLASTOMA SCREENING FEASIBILITY STUDY IN FRANCE - METHODOLOGY AND PRELIMINARY-OBSERVATIONS
    Early human development
    
    P. Mathieu et al., "A 5-YEAR (1990-1994) NEUROBLASTOMA SCREENING FEASIBILITY STUDY IN FRANCE - METHODOLOGY AND PRELIMINARY-OBSERVATIONS", Early human development, 46(1-2), 1996, pp. 177-196
19. THOMAS CP; BURONFOSSE A; COMBARET V; PEDRON S; FERTIL B; PORTOUKALIAN J
    GANGLIOSIDES PROTECT HUMAN-MELANOMA CELLS FROM IONIZING RADIATION-INDUCED CLONOGENIC CELL-DEATH
    Glycoconjugate journal
    
    C.P. Thomas et al., "GANGLIOSIDES PROTECT HUMAN-MELANOMA CELLS FROM IONIZING RADIATION-INDUCED CLONOGENIC CELL-DEATH", Glycoconjugate journal, 13(3), 1996, pp. 377-384
20. FRAPPAZ D; BERARD PM; COMBARET V; THIESSE P; BASSET T; BOUFFET E; POUYAU G; DESUZINGES C; MENTIGNY MB; PHILIP T
    UNUSUAL SITE OF RELAPSE FOR A NEUROBLASTO MA - ONE CASE OF INTRACRANIAL RELAPSE
    Bulletin du cancer
    
    D. Frappaz et al., "UNUSUAL SITE OF RELAPSE FOR A NEUROBLASTO MA - ONE CASE OF INTRACRANIAL RELAPSE", Bulletin du cancer, 83(3), 1996, pp. 239-242
21. BOUFFET E; MICHON J; FRAPPAZ D; NEGRIER S; COMBARET V; DELATTRE O; COCHAT P; FLORET D; DOZ F; STAMM D; CLAPISSON G; OSKAM R; LASSET C; PACQUEMENT H; ZUCKER JM; BRUNATMENTIGNY M; FAVROT M; PHILIP T
    PILOT-STUDY OF IMMUNOTHERAPY USING INTERLEUKIN-2 IN CHILDREN WITH SOLID TUMORS OR LYMPHOMAS
    International journal of pediatric hematology/oncology
    
    E. Bouffet et al., "PILOT-STUDY OF IMMUNOTHERAPY USING INTERLEUKIN-2 IN CHILDREN WITH SOLID TUMORS OR LYMPHOMAS", International journal of pediatric hematology/oncology, 2(6), 1995, pp. 489-493
22. COMBARET V; LASSET C; FRAPPAZ D; BOUVIER R; THIESSE P; REBILLARD AC; PHILIP T; FAVROT MC
    EVALUATION OF CD44 PROGNOSTIC VALUE IN NEUROBLASTOMA - COMPARISON WITH THE OTHER PROGNOSTIC FACTORS
    European journal of cancer
    
    V. Combaret et al., "EVALUATION OF CD44 PROGNOSTIC VALUE IN NEUROBLASTOMA - COMPARISON WITH THE OTHER PROGNOSTIC FACTORS", European journal of cancer, 31A(4), 1995, pp. 545-549
23. MERROUCHE Y; NEGRIER S; BAIN C; COMBARET V; MERCATELLO A; CORONEL B; MOSKOVTCHENKO JF; TOLSTOSHEV P; MOEN R; PHILIP T; FAVROT MC
    CLINICAL-APPLICATION OF RETROVIRAL GENE-TRANSFER IN ONCOLOGY - RESULTS OF A FRENCH STUDY WITH TUMOR-INFILTRATING LYMPHOCYTES TRANSDUCED WITH THE GENE OF RESISTANCE TO NEOMYCIN
    Journal of clinical oncology
    
    Y. Merrouche et al., "CLINICAL-APPLICATION OF RETROVIRAL GENE-TRANSFER IN ONCOLOGY - RESULTS OF A FRENCH STUDY WITH TUMOR-INFILTRATING LYMPHOCYTES TRANSDUCED WITH THE GENE OF RESISTANCE TO NEOMYCIN", Journal of clinical oncology, 13(2), 1995, pp. 410-418
24. COMBARET V; TURCCAREL C; THIESSE P; REBILLARD AC; FRAPPAZ D; HAUS O; PHILIP T; FAVROT MC
    SENSITIVE DETECTION OF NUMERICAL AND STRUCTURAL-ABERRATIONS OF CHROMOSOME-1 IN NEUROBLASTOMA BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION - COMPARISON WITH RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM AND CONVENTIONAL CYTOGENETIC ANALYSES
    International journal of cancer
    
    V. Combaret et al., "SENSITIVE DETECTION OF NUMERICAL AND STRUCTURAL-ABERRATIONS OF CHROMOSOME-1 IN NEUROBLASTOMA BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION - COMPARISON WITH RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM AND CONVENTIONAL CYTOGENETIC ANALYSES", International journal of cancer, 61(2), 1995, pp. 185-191
25. COMBARET V; LASSET C; BOUVIER R; FRAPPAZ D; THIESSE P; REBILLARD AC; PHILIP T; FAVROT MC
    CD44, A NEW PROGNOSTIC MARKER FOR NEUROBL ASTOMA
    Bulletin du cancer
    
    V. Combaret et al., "CD44, A NEW PROGNOSTIC MARKER FOR NEUROBL ASTOMA", Bulletin du cancer, 82(2), 1995, pp. 131-136
26. FRAPPAZ D; BOUFFET E; THIESSE P; MOTTOLESE C; ARTIGES V; GRABOIS M; COMBARET V; DESUZINGES C; FAVROT M; MENTIGNY MB; PHILIP T
    ISOLATED INTRASPINAL RELAPSE OF NEUROBLASTOMA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    Pediatric hematology and oncology
    
    D. Frappaz et al., "ISOLATED INTRASPINAL RELAPSE OF NEUROBLASTOMA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION", Pediatric hematology and oncology, 11(4), 1994, pp. 439-443
27. COMBARET V; COLL JL; FAVROT MC
    EXPRESSION OF INTEGRIN AND CD44 ADHESION MOLECULES ON NEUROBLASTOMA -THE RELATION TO TUMOR AGGRESSIVENESS AND EMBRYONIC NEURAL-CREST DIFFERENTIATION
    Invasion & metastasis
    
    V. Combaret et al., "EXPRESSION OF INTEGRIN AND CD44 ADHESION MOLECULES ON NEUROBLASTOMA -THE RELATION TO TUMOR AGGRESSIVENESS AND EMBRYONIC NEURAL-CREST DIFFERENTIATION", Invasion & metastasis, 14(1-6), 1994, pp. 156-163
28. LADENSTEIN R; FAVROT M; LASSET C; BOUFFET E; PHILIP I; COMBARET V; CHAUVIN F; BRUNATMENTIGNY M; BIRON P; PHILIP T
    INDICATION AND LIMITS OF MEGATHERAPY AND BONE-MARROW TRANSPLANTATION IN HIGH-RISK NEUROBLASTOMA - A SINGLE CENTER ANALYSIS OF PROGNOSTIC FACTORS
    European journal of cancer
    
    R. Ladenstein et al., "INDICATION AND LIMITS OF MEGATHERAPY AND BONE-MARROW TRANSPLANTATION IN HIGH-RISK NEUROBLASTOMA - A SINGLE CENTER ANALYSIS OF PROGNOSTIC FACTORS", European journal of cancer, 29A(7), 1993, pp. 947-956
29. ZUCMAN J; MELOT T; DESMAZE C; GHYSDAEL J; PLOUGASTEL B; PETER M; ZUCKER JM; TRICHE TJ; SHEER D; TURCCAREL C; AMBROS P; COMBARET V; LENOIR G; AURIAS A; THOMAS G; DELATTRE O
    COMBINATORIAL GENERATION OF VARIABLE FUSION PROTEINS IN THE EWING FAMILY OF TUMORS
    EMBO journal
    
    J. Zucman et al., "COMBINATORIAL GENERATION OF VARIABLE FUSION PROTEINS IN THE EWING FAMILY OF TUMORS", EMBO journal, 12(12), 1993, pp. 4481-4487
30. FAVROT MC; COMBARET V; LASSET C
    CD44 - A NEW PROGNOSTIC MARKER FOR NEUROBLASTOMA
    The New England journal of medicine
    
    M.C. Favrot et al., "CD44 - A NEW PROGNOSTIC MARKER FOR NEUROBLASTOMA", The New England journal of medicine, 329(26), 1993, pp. 1965-1965